John Gore, PhD, director of the Vanderbilt University Institute of Imaging Science (VUIIS), and Michael King, PhD, J. Lawrence Wilson Professor and chair of the Department of Biomedical Engineering at Vanderbilt University, were recently elected to the International Academy of Medical and Biological Engineering (IAMBE) 2019 Class of Fellows in recognition of their contributions in the field of medical and biological engineering.
News: May, 2019
Shari Barkin, MD, MSHS, division chief of General Pediatrics at Monroe Carell Jr. Children’s Hospital at Vanderbilt, was honored recently with the 2019 Academic Pediatric Association (APA) Research Award.
Mariana Byndloss, DVM, PhD, assistant professor of Pathology, Microbiology and Immunology, has been selected to participate in the Future Research Leaders Conference at the National Institutes of Health (NIH).
Vanderbilt University researchers have discovered how a protein pump distinguishes between chemicals that it will expel from a cell and inhibitors that block its action – findings that could guide the development of more efficient inhibitors to prevent cancer cell resistance to chemotherapy.
Bioimpedance spectroscopy (BIS) is better than a tape measure for assessing a woman’s risk for developing lymphedema, painful swelling in the arm after breast cancer surgery, according to interim results of a recent study.
A recent study presents a new way to analyze the repair of basement membranes, important structural and functional components of tissues that are subject to environmental damage.
Joseph Smith Jr., MD, professor of Urologic Surgery, has been awarded the Keyes Medal from the American Association of Genitourinary Surgeons (AAGUS).
Vanderbilt Dermatology in collaboration with the Nashville Dermatology Society is offering free skin cancer screenings on Saturday, June 15, from 9 a.m. to noon at Vanderbilt Health One Hundred Oaks, 719 Thompson Lane, Suite 26300.
Mary Jo Gilmer, PhD, recently received a grant from nonprofit Human Animal Bond Research Institute (HABRI) for a pilot program investigating the health benefits of human-animal interactions (HAIs) in reducing suffering of children with cancer undergoing debilitating treatments.
A recent study suggests that blocking the MYC protein could be “unexpectedly effective” in treating malignant rhabdoid tumor (MRT) is one of the most aggressive and lethal childhood cancers.